Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
BAKX Therapeutics Logo
BAKX Therapeutics Growth Score
35
CB Rank
68095
Heat Score
21
BAKX Therapeutics is a provider of cancer treatment.
Founded
obfuscation
PrivateSeries A Boston, New York, United States11-50 bakxtx.com/
Biotechnology
Health Care
Medical
Oncology
Therapeutics
Overview

BAKX Therapeutics
Total Funding
obfuscation
Growth Score
35
Heat Score
21

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score35
-2 pts
in past quarter
Heat Score 21
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About BAKX Therapeutics

CB Rank
68095
BAKX Therapeutics is a provider of cancer treatment.
Founded
obfuscation
PrivateSeries A Boston, New York, United States11-50 bakxtx.com/
Biotechnology
Health Care
Medical
Oncology
Therapeutics

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name BAKX Therapeutics Inc.
Operating Status Active
Company Type For Profit
Founders  Sree Kant
About the Company
BAKX Therapeutics is a provider of cancer treatment.
Contact Email info@bakxtx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A
obfuscation
Series A - BAKX Therapeutics Logo
Series A - BAKX Therapeutics
3
obfuscation
AB Magnitude Ventures Group, Ipsen, Sherpa Healthcare PartnersSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 2 Contacts 6

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jul 11, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 18, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$182.3KThis year, BAKX Therapeutics is projected to spend $182.3K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Fee-Based Advisor Logo
Fee-Based Advisor
90
Independent Financial Practice Logo
Independent Financial Practice
78
Dow Jones Logo
Dow Jones
75

Active Website Tech Count

3BAKX Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Euro and  CommonCrawl Top 5m.
Sub-Organizations
Frequently Asked Questions

Where is BAKX Therapeutics's headquarters? BAKX Therapeutics is located in Boston, New York, United States.Who invested in BAKX Therapeutics? BAKX Therapeutics has 3 investors including Ipsen and  AB Magnitude Ventures Group.When was the last funding round for BAKX Therapeutics? BAKX Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are BAKX Therapeutics's competitors? Alternatives and possible competitors to BAKX Therapeutics may include Relay Therapeutics, Lytix Biopharma, and  Revolution Medicines.How much funding has BAKX Therapeutics raised to date? BAKX Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|